Day Trader తెలుగు
14:32 · May 12, 2023 · Fri
SOLARA ACTIVE PHARMA SCIENCES: Q4 EBITDA 490M RUPEES VS 135M (YOY) || Q4 EBITDA MARGIN 12.86% VS 3.75% (YOY)
Please enable JavaScript to view the
comments powered by Disqus.
Home